Dystroglycan function appears to be disrupted in numerous epithelial derived cancers [9,80,81] though the precise functional role of dystroglycan in this context is not clear, but probably involves aspects of both cell adhesion and cell migration, and possibly its putative nuclear function. The gene discussed is DAG1; the disease is cancer.